Long-Term Survival and Late Effects among One-Year Survivors of Second Allogeneic Hematopoietic Cell Transplantation for Relapsed Acute Leukemia and Myelodysplastic Syndromes
Christine Duncan(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Mohamed L. Sorror(University of Washington Medical Center), Maxim Norkin(University of Florida Health), Robert J. Hayashi(Washington University in St. Louis), William A. Wood(University of North Carolina at Chapel Hill), Navneet S. Majhail(Sarah Cannon), Haydar Frangoul(Children’s Hospital at TriStar Centennial), Kimberly A. Kasow(University of North Carolina at Chapel Hill), Vijay Reddy(University of Florida), Harry C. Schouten, Alison W. Loren(University of Pennsylvania), Hillard M. Lazarus(University Hospitals of Cleveland), David L. Porter(Chapman University), Nandita Khera(Mayo Clinic in Florida), Wael Saber(Medical College of Wisconsin), Lolie C. Yu(Louisiana State University), Ruta Brazauskas(Medical College of Wisconsin), David A. Jacobsohn(Children's National), Amir Steinberg(New York Medical College), Richard T. Maziarz(Oregon Health & Science University), Bipin N. Savani(Vanderbilt University Medical Center), Anne B. Warwick(Uniformed Services University of the Health Sciences), Zhiwei Wang(Wenzhou Medical University), Joseph A. Pidala(Moffitt Cancer Center), Rammurti T. Kamble(Baylor College of Medicine), Paulette Mehta(Central Arkansas Veterans Healthcare System), Jean‐Yves Cahn(Université Grenoble Alpes), David I. Marks(University Hospitals Bristol NHS Foundation Trust), Donna A. Wall(University of Manitoba), Jack W. Hsu(University of Florida Health), Kasiani C. Myers(Immune Deficiency Foundation)
Cited by 64
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
|New England Journal of Medicine|2020|1.8k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.1k
Voriconazole Compared with Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Neutropenia and Persistent Fever
|New England Journal of Medicine|2002|986